Dr. James Parker Callaway, MD

Dr. Callaway practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Callaway's NPI, 1215198577, was assigned on June 19, 2008. Dr. Callaway graduated from Medical College of Georgia School of Medicine in 2008. Dr. Callaway holds Alabama license 29881.

Dr. Callaway's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Callaway's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Callaway is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Callaway to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Callaway practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Callaway's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Callaway is licensed in Alabama.

CMS data shows 412 Medicare services from Dr. Callaway across 11 procedure codes in 2024, for 255 Medicare patients. Medicare paid $30,317 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 255 Medicare patients who saw Dr. Callaway in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Callaway's median patient age at 62, with 66% women.

In 2024, Dr. Callaway wrote 376 Medicare Part D claims for 113 patients. 71% of them were for generic drugs. CMS names the drug for 259 of them, across 12 drugs with 11 or more claims each, at $749,073 in total drug cost. In 2023, CMS named 222 claims across 10 drugs.

Dr. Callaway accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Callaway as offering telehealth. CMS counts 268 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Callaway, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Callaway, published from 2018 to 2025. The most frequent topics are Manometry. Dr. Callaway has published most often in Abdom Radiol (NY). Dr. Callaway's most frequent co-authors are Desiree E. Morgan, Michael F. Vaezi, MD, PhD and Jessica Garrette Zarzour.

CMS Open Payments shows 75 general payments to Dr. Callaway from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Sanofi and Genzyme US Companies paid the most, $10,776.

Dr. Callaway graduated from Medical College of Georgia School of Medicine in 2008.